Work

Outcome with the Hyper-CVAD and Rituximab Regimen in Burkitt (BL) and Burkitt-Like (BLL) Leukemia/Lymphoma.

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.3297.3297

Authors: Deborah A. Thomas, Jorge Cortes, Stefan Faderl, Susan O’Brien, Miloslav Beran, Charles Koller, Guillermo Garcia-Manero, Anas Younes, Luis Fayad, William Wierda, Sherry Pierce, Francis J. Giles, Hagop Kantarjian

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2557704303

FWCI: 1.593

Cites:

Cited by: 7

Related to: 10